Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
Notice Number: NOT-DA-11-026
Release Date: March 24, 2011
National Institute on Drug Abuse (NIDA)
The National Institute on Drug Abuse (NIDA) plans on issuing a solicitation seeking qualified businesses with the capability conduct a large national longitudinal cohort study and establish a regulatory-science framework to monitor the behavioral and health impacts of provisions in the 2009 Family Smoking Prevention and Tobacco Control Act (FSPTCA). A solicitation will be released through the Federal Business Opportunies website( URL: https://www.fbo.gov/ ). The RFP will be released on or about April 5, 2011 and proposals will be due approximately 45 days thereafter.
Research Initiative Details
The FSPTCA gave the Food and Drug Administration (FDA) the authority to regulate tobacco-product advertising, labeling, marketing, constituents, ingredients and additives in the United States. These regulatory changes are expected to influence tobacco-product risk perceptions, use patterns, and exposures, and to reduce tobacco-related morbidity and mortality over time. The study initially will focus on designing the sample, establishing the cohort, collecting data on a yearly basis, developing a database, arranging a central specimen repository, and measuring and reporting on the near-term behavioral and health effects of the regulatory changes. NIDA anticipates that over time, the study will involve continued cohort monitoring, additional recruitment of young adults to the cohort at each wave, cross-sectional analyses within age groups and longitudinal data analysis, including analysis of distal outcomes, and small area estimation modeling. Results from this study are expected to inform the development, implementation, and evaluation of tobacco-product regulations in the United States (For detailed information on FSPTCA, see http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=111_cong_public_laws&docid=f:publ031.111.pdf).
Please direct all inquiries to:
Brian H. O’Laughlin
NIDA R&D Contracts Management Branch
Office of Acquisitions, NIDA
National Institutes of Health
6001 Executive Blvd., Room 4211 (MSC 9559)
Bethesda, MD 20892-9559
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.